Procter & Gamble Health Share Price
Start SIP in Procter & Gamble Health
Start SIPProcter & Gamble Health Performance
Day Range
- Low 5,494
- High 5,742
52 Week Range
- Low 4,637
- High 5,742
- Open Price5,584
- Previous Close5,287
- Volume128499
Procter & Gamble Health Investment Rating
-
Master Rating:
-
P&G Health is a leading global healthcare company specializing in consumer health products, including over-the-counter medications and dietary supplements. With a focus on innovation and quality, it aims to enhance the well-being of individuals and families worldwide. Procter & Gamble Health has an operating revenue of Rs. 1,151.26 Cr. on a trailing 12-month basis. An annual revenue de-growth of -6% needs improvement, Pre-tax margin of 24% is great, ROE of 37% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its key moving averages, around -0% and 3% from 50DMA and 200DMA. It needs to stay above these levels to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 5% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 19 which is a POOR score indicating inconsistency in earnings, a RS Rating of 41 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 32 indicates it belongs to a strong industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 313 | 284 | 252 | 310 | 305 | 301 | 321 |
| Operating Expenses Qtr Cr | 199 | 236 | 185 | 208 | 216 | 256 | 243 |
| Operating Profit Qtr Cr | 114 | 48 | 67 | 102 | 89 | 45 | 80 |
| Depreciation Qtr Cr | 6 | 7 | 7 | 7 | 6 | 6 | 6 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 29 | 6 | 16 | 28 | 22 | 14 | 19 |
| Net Profit Qtr Cr | 82 | 17 | 47 | 72 | 66 | 30 | 59 |
Procter & Gamble Health Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹5,211.44
- 50 Day
- ₹5,215.95
- 100 Day
- ₹5,175.95
- 200 Day
- ₹5,109.79
- 20 Day
- ₹5,189.28
- 50 Day
- ₹5,241.08
- 100 Day
- ₹5,199.74
- 200 Day
- ₹5,074.17
Procter & Gamble Health Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 5,692.92 |
| Second Resistance | 5,841.78 |
| Third Resistance | 5,941.17 |
| RSI | 67.07 |
| MFI | 82.45 |
| MACD Single Line | -33.47 |
| MACD | 4.05 |
| Support | |
|---|---|
| First Support | 5,444.67 |
| Second Support | 5,345.28 |
| Third Supoort | 5,196.42 |
Procter & Gamble Health Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 132,201 | 2,670,460 | 20.2 |
| Week | 32,721 | 795,443 | 24.31 |
| 1 Month | 11,248 | 371,422 | 33.02 |
| 6 Month | 10,463 | 599,089 | 57.26 |
Procter & Gamble Health Result Highlights
Procter & Gamble Health Synopsis
NSE-Medical-Generic Drugs
P&G Health, a division of Procter & Gamble, is a prominent player in the global healthcare sector, dedicated to providing high-quality consumer health products. The company specializes in a diverse range of over-the-counter medications, dietary supplements, and wellness solutions that cater to the health needs of individuals and families. Known for its commitment to innovation and research, P&G Health develops products that are backed by science and designed to improve quality of life. The company focuses on consumer education and responsible marketing, ensuring that its offerings promote health and well-being while contributing positively to communities around the world.| Market Cap | 8,776 |
| Sales | 1,151 |
| Shares in Float | 0.80 |
| No of funds | 141 |
| Yield | 2.1 |
| Book Value | 16.25 |
| U/D Vol ratio | 1.5 |
| LTDebt / Equity | |
| Alpha | -0.01 |
| Beta | 0.28 |
Procter & Gamble Health Shareholding Pattern
| Owner Name | Sep-24 | Jun-24 | Mar-24 | Dec-23 |
|---|---|---|---|---|
| Promoters | 51.82% | 51.82% | 51.82% | 51.82% |
| Mutual Funds | 10.45% | 10.19% | 9.86% | 8.98% |
| Insurance Companies | 4.09% | 4.05% | 3.55% | 3.41% |
| Foreign Portfolio Investors | 6.61% | 6.39% | 6.24% | 7.6% |
| Financial Institutions/ Banks | ||||
| Individual Investors | 21.46% | 21.83% | 22.61% | 22.9% |
| Others | 5.57% | 5.72% | 5.92% | 5.29% |
Procter & Gamble Health Management
| Name | Designation |
|---|---|
| Mr. Suresh Talwar | Chairman & Ind.Director |
| Mr. Milind Thatte | Managing Director |
| Mr. Lokesh Chandak | Executive Director & CFO |
| Ms. Seema Sambasivan | Non Executive Director |
| Mr. Aalok Agrawal | Non Executive Director |
| Mrs. Rani Jadhav | Independent Director |
| Mr. S Madhavan | Independent Director |
Procter & Gamble Health Forecast
Price Estimates
Procter & Gamble Health Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-11-04 | Quarterly Results | |
| 2024-08-21 | Audited Results & Final Dividend | |
| 2024-05-02 | Quarterly Results | |
| 2024-02-06 | Quarterly Results & Interim Dividend | |
| 2023-11-03 | Quarterly Results |
| Date | Purpose | Remarks |
|---|---|---|
| 2024-02-14 | INTERIM | Rs.50.00 per share(500%)Interim Dividend |
| 2024-02-14 | SPECIAL | Rs.150.00 per share(1500%)Special Dividend |
| 2023-02-13 | INTERIM | Rs.45.00 per share(450%)Interim Dividend |
| 2022-05-13 | INTERIM | Rs.41.00 per share(410%)Interim Dividend |
Procter & Gamble Health FAQs
What is Share Price of Procter & Gamble Health ?
Procter & Gamble Health share price is ₹5,544 As on 05 November, 2024 | 21:50
What is the Market Cap of Procter & Gamble Health ?
The Market Cap of Procter & Gamble Health is ₹9202.8 Cr As on 05 November, 2024 | 21:50
What is the P/E ratio of Procter & Gamble Health ?
The P/E ratio of Procter & Gamble Health is 42.3 As on 05 November, 2024 | 21:50
What is the PB ratio of Procter & Gamble Health ?
The PB ratio of Procter & Gamble Health is 17.1 As on 05 November, 2024 | 21:50
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.